Tapentadol, the new kid on the block in India: Is it time to worry?
Indian J Psychiatry
; 62(6): 697-702, 2020.
Article
em En
| MEDLINE
| ID: mdl-33896976
ABSTRACT
BACKGROUND AND OBJECTIVES:
Large-scale prospective case series of tapentadol abuse or dependence in India is not available. Hence, we aimed to study the prevalence and profile of tapentadol users in a treatment-seeking population. MATERIALS ANDMETHODS:
The study had prospective and retrospective arms. We collected 8-month prospective data by face-to-face interviews (n = 70) and 8-year retrospective data from case notes (n = 26) with either tapentadol misuse/abuse or dependence in patients attending a de-addiction center.RESULTS:
The prevalence of tapentadol abuse or dependence was 25% among the pharmaceutical opioid users. Concurrent use of other opioids was seen in >80% of participants of both the arms. Major sources of tapentadol were chemists (without a prescription) (53%) and doctors (prescriptions) (40%). Patients in the tapentadol dependence group had a significantly higher dose, duration, and pharmaceutical opioid use.CONCLUSION:
India needs awareness promotion, training, availability restriction, and provision of treatment for tapentadol abuse or dependence.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Qualitative_research
/
Risk_factors_studies
Idioma:
En
Revista:
Indian J Psychiatry
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
Índia